Vanguard Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.7M Buy
253,146
+26,416
+12% +$5.18M 0.04% 391
2026
Q1
$44.4M Buy
+226,730
New +$44.1M 0.04% 391

Other funds holding DGX

Vanguard Asset Management's DGX Position: Q2 2026 in Review

Vanguard Asset Management increased its Quest Diagnostics (DGX) stake by 12% in Q2 2026, buying an estimated $5.18M and bringing the position to 253,146 shares worth $53.7M. The position accounts for 0.04% of the portfolio, ranked #391.

Vanguard Asset Management first reported a position in DGX in Q1 2026 and has held it in 2 quarters since. 1,046 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Vanguard Asset Management held 253,146 shares of Quest Diagnostics worth $53.7M as of Q2 2026.
  • Vanguard Asset Management bought 26,416 Quest Diagnostics shares in Q2 2026, an estimated $5.18M.
  • Quest Diagnostics made up 0.04% of Vanguard Asset Management's portfolio in Q2 2026, its #391 holding.
  • Vanguard Asset Management first reported a position in Quest Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.